Tacrolimus topical spray - Lipidor
Alternative Names: AKP-07Latest Information Update: 28 Jun 2024
At a glance
- Originator Lipidor
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Antiglaucomas; Antipsoriatics; Antirheumatics; Eye disorder therapies; Lactones; Macrolides; Skin disorder therapies; Urologics; Vascular disorder therapies
- Mechanism of Action Calcineurin inhibitors; Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Preclinical Eczema
- No development reported Atopic dermatitis
Most Recent Events
- 28 Jun 2024 No recent reports of development identified for preclinical development in Atopic-dermatitis in Sweden (Topical)
- 12 Jan 2023 Preclinical trials in Eczema in Sweden (Topical, Spray) (Lipidor pipeline, January 2023)
- 07 May 2020 Preclinical trials in Atopic dermatitis in Sweden (Topical)